Commit To Buy Neumora Therapeutics At $5, Earn 105.2% Annualized Using Options
December 20, 2024 at 11:51 AM EST
Investors considering a purchase of Neumora Therapeutics Inc (NMRA) stock, but tentative about paying the going market price of $10.71/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2025 put at the $5 strike, which has a bid at the time of this writing of $1.70..